Advances in Precision Cancer Care for Community Practitioners: A Focus on NTRK- and RET-Altered Malignancies

Download slides and view an on-demand webcast from a live meeting on recent advances in treating patients with cancer in the community setting who have NTRK- and RET-altered malignancies.

Share

Program Content

Activities

<i>NTRK</i>- and <i>RET</i>-Altered Malignancies
Advances in Precision Cancer Care for Community Practitioners: A Focus on NTRK- and RET-Altered Malignancies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2022

Expires: August 03, 2023

Activities

<i>NTRK</i>- and <i>RET</i>-altered cancers
Advances in Precision Cancer Care for Community Practitioners: A Focus on NTRK- and RET-Altered Malignancies
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2022

Expires: June 09, 2023

Faculty

cover img faculity

Alexander Drilon, MD

Chief, Early Drug Development
Attending, Thoracic
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Thomas Stinchcombe, MD

Medical Oncologist
Thoracic Oncology Program
Duke University Medical Center
Durham, North Carolina

cover img faculity

Saad A. Khan, MD

Leader, Endocrine Cancer Research Group
Assistant Professor
Stanford University and Stanford Cancer Institute
Stanford, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Lilly